190 related articles for article (PubMed ID: 25478034)
1. Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer.
Kar S; Sengupta D; Deb M; Shilpi A; Parbin S; Rath SK; Pradhan N; Rakshit M; Patra SK
Clin Epigenetics; 2014; 6(1):20. PubMed ID: 25478034
[TBL] [Abstract][Full Text] [Related]
2. Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma.
Sanaei M; Kavoosi F; Roustazadeh A; Golestan F
J Clin Transl Hepatol; 2018 Jun; 6(2):141-146. PubMed ID: 29951358
[No Abstract] [Full Text] [Related]
3. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases.
Vincent A; Ducourouble MP; Van Seuningen I
FASEB J; 2008 Aug; 22(8):3035-45. PubMed ID: 18492726
[TBL] [Abstract][Full Text] [Related]
10. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
[TBL] [Abstract][Full Text] [Related]
12. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
13. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
Wozniak RJ; Klimecki WT; Lau SS; Feinstein Y; Futscher BW
Oncogene; 2007 Jan; 26(1):77-90. PubMed ID: 16799634
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
Ballestar E; Paz MF; Valle L; Wei S; Fraga MF; Espada J; Cigudosa JC; Huang TH; Esteller M
EMBO J; 2003 Dec; 22(23):6335-45. PubMed ID: 14633992
[TBL] [Abstract][Full Text] [Related]
16. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
17. Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins.
Mirza S; Sharma G; Parshad R; Gupta SD; Pandya P; Ralhan R
J Breast Cancer; 2013 Mar; 16(1):23-31. PubMed ID: 23593078
[TBL] [Abstract][Full Text] [Related]
18. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
19. The Effect of 5-Aza-2'-Deoxycytidine in Combination to and in Comparison with Vorinostat on DNA Methyltransferases, Histone Deacetylase 1, Glutathione S-Transferase 1 and Suppressor of Cytokine Signaling 1 Genes Expression, Cell Growth Inhibition and Apoptotic Induction in Hepatocellular LCL-PI 11 Cell Line.
Sanaei M; Kavoosi F; Esmi Z
Int J Hematol Oncol Stem Cell Res; 2020 Jan; 14(1):45-55. PubMed ID: 32337014
[No Abstract] [Full Text] [Related]
20. Hippocampal chromatin-modifying enzymes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment.
Singh P; Konar A; Kumar A; Srivas S; Thakur MK
J Neurochem; 2015 Aug; 134(4):642-51. PubMed ID: 25982413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]